title: Lactase treated feeds to promote growth and feeding tolerance in preterm infants.
abstract: BACKGROUND
  Successful transition from parenteral nutrition to full enteral feedings during the immediate neonatal period is associated with improved growth in preterm infants. Lactase is the last of the major intestinal disaccharidases to develop in preterm infants. Because of inadequate lactase activity, preterm infants are unable to digest lactose. Lactase preparations could potentially be used to hydrolyse lactose in formulas and breast milk to minimize lactose malabsorption in preterm infants.
  
  
  OBJECTIVE
  To assess the effectiveness and safety of the addition of lactase to milk compared to placebo or no intervention for the promotion of growth and feeding tolerance in preterm infants.
  
  
  METHODS
  weight gain expressed as grams/kg/day, growth expressed as weight, length and head circumference percentile for postmenstrual age (PMA), assessed at birth and at 40 weeks PMA, days to achieve full enteral feeds.
  
  
  RESULTS
  several common outcomes associated with preterm birth, and adverse effects.
  
  
  METHODS
  Electronic and manual searches were conducted in January 2005 of the Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library, 2004, Issue 4), MEDLINE (1966 to Jan 2005), EMBASE (1980 to Jan 2005) and CINAHL (1982 to Jan 2005), personal files, bibliographies of identified trials and abstracts by the Pediatric Academic Societies' Meetings and the European Society of Pediatric Research Meetings published in Pediatric Research. The searches were repeated in May 2012 of The Cochrane Library, MEDLINE, EMBASE and CINAHL and abstracts from the Pediatric Academic Societies' Annual Meetings from 2000 to 2012 (Abstracts2View). The Web of Science was searched using the only previously identified trial by Erasmus 2002 as the starting point to search for additional trials that cited this trial.
  
  
  METHODS
  Types of studies: randomized or quasi-randomized controlled trials.
  
  
  METHODS
  preterm infants < 37 weeks PMA.
  
  
  METHODS
  addition of lactase to milk versus placebo or no intervention.
  
  
  METHODS
  The standard methods of the Cochrane Neonatal Review Group were followed independently by the review authors to assess study quality and report outcomes. Treatment effects, calculated using Review Manager 5, included risk ratio (RR), risk difference (RD) and mean difference (MD), all with 95% confidence intervals (CI). A fixed-effect model was used for meta-analyses. We did not perform heterogeneity tests as only one study was identified.
  
  
  RESULTS
  The repeat searches conducted in May 2012 did not identify any additional studies for inclusion. One study enrolling 130 infants of 26 to 34 weeks PMA (mean postnatal age at entry 11 days) was identified and no identified study was excluded. The study was a double blind randomized controlled trial of high quality. Lactase treated feeds were initiated when enteral feedings provided > 75% of daily intake. None of the primary outcomes outlined in the protocol for this review and only one of the secondary outcomes, necrotizing enterocolitis (NEC) were reported on. The RR for NEC was 0.32 (95% CI 0.01 to 7.79); the RD was -0.02 (95% CI -0.06 to 0.03) (a reduction which was not statistically significant). There was a statistically significant increase in weight gain at study day 10 in the lactase treated feeds group but not at any other time points. Overall, there was not a statistically significant effect on weight gain. No adverse effects were noted.
  
  
  CONCLUSIONS
  The only randomized trial to date provides no evidence of significant benefit to preterm infants from adding lactase to their feeds. Further research regarding effectiveness and safety are required before practice recommendations can be made. Randomized controlled trials comparing lactase versus placebo treated feeds and enrolling infants when enteral feeds are introduced are required. The primary and secondary outcomes for effectiveness and safety should include those identified in this review.
authors.affiliation: Pediatrix Medical Group Washington, Renton, Washington, USA. cherrie_tan-dy@pediatrix.com.
authors.forename: Cherrie Rose Y
authors.initials: CR
authors.lastname: Tan-Dy
authors.forename: Arne
authors.initials: A
authors.lastname: Ohlsson
mesh_terms: D004750:Enteral Nutrition; D006801:Humans; D007227:Infant Nutritional Physiological Phenomena; D007231:Infant, Newborn; D007234:Infant, Premature / Q000254:growth & development*; D043322:Lactase / Q000627:therapeutic use*; D007787:Lactose Intolerance / Q000517:prevention & control; D010288:Parenteral Nutrition; D016032:Randomized Controlled Trials as Topic; D015430:Weight Gain
chemical_list: D043322:Lactase
references.citation: J Pediatr. 1999 Nov;135(5):587-92
references.pmid: 10547247
references.citation: CMAJ. 1995 Jun 1;152(11):1765-85
references.pmid: 7773894
references.citation: J Pediatr Gastroenterol Nutr. 2002 Sep;35(3):298-302
references.pmid: 12352516
references.citation: JPEN J Parenter Enteral Nutr. 1979 Nov-Dec;3(6):459-61
references.pmid: 119065
references.citation: J Pediatr. 1975 Oct;87(4):602-5
references.pmid: 1174138
references.citation: Int J Food Sci Nutr. 1999 Sep;50(5):311-7
references.pmid: 10719561
references.citation: Early Hum Dev. 1986 Apr;13(2):225-34
references.pmid: 3086071
references.citation: JPEN J Parenter Enteral Nutr. 1991 Sep-Oct;15(5):564-6
references.pmid: 1942472
references.citation: Pediatrics. 2003 Jul;112(1 Pt 1):e30-8
references.pmid: 12837903
references.citation: Gastroenterology. 1974 Nov;67(5):975-82
references.pmid: 4214726
references.citation: Gastroenterology. 1974 Jul;67(1):51-8
references.pmid: 4858137
references.citation: J Obstet Gynecol Neonatal Nurs. 2002 Jan-Feb;31(1):57-65
references.pmid: 11843020
references.citation: Pediatrics. 1999 Aug;104(2 Pt 1):280-9
references.pmid: 10429008
references.citation: BMJ. 2003 Sep 6;327(7414):557-60
references.pmid: 12958120
references.citation: Pediatrics. 1993 May;91(5):922-6
references.pmid: 8474812
references.citation: Clin Perinatol. 1995 Mar;22(1):195-205
references.pmid: 7781252
references.citation: J Am Diet Assoc. 1991 Dec;91(12):1567-71
references.pmid: 1960350
references.citation: Pediatrics. 1965 Jun;35:944-54
references.pmid: 14296420
references.citation: Acta Paediatr. 2002;91(3):292-6
references.pmid: 12022301
references.citation: Cochrane Database Syst Rev. 2005 Apr 18;(2):CD004591
references.pmid: 15846722
references.citation: Pediatrics. 1977 Oct;60(4):535-8
references.pmid: 905019
references.citation: Acta Paediatr Jpn. 1996 Oct;38(5):449-54
references.pmid: 8942002
references.citation: J Pediatr. 1998 Nov;133(5):645-9
references.pmid: 9821422
references.citation: Clin Perinatol. 1996 Jun;23(2):229-43
references.pmid: 8780903
references.citation: Clin Sci (Lond). 1980 Nov;59(5):317-27
references.pmid: 6775859
references.citation: J Pediatr. 2002 Oct;141(4):532-7
references.pmid: 12378193
references.citation: Clin Perinatol. 1996 Jun;23(2):211-28
references.pmid: 8780902